Brief: Samsung Pharmaceutical lowers conversion price of 26th series convertible bonds to 9,129 won/share
Jan 24 (Reuters) - Samsung Pharmaceutical Co Ltd 001360.KS
:
* Says it lowered conversion price of 26th series
convertible bonds to 9,129 won/share from 9,130 won/share,
effective Jan. 23
Source text in Korean: https://goo.gl/lH6VNC
Further company coverage: 001360.KS
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 010 62674724;
Reuters Messaging: hedy.cui.reuters.com@reuters.net))
Recent news on Samsung Pharm
See all newsBrief: Samsung Pharmaceutical Wins 33.5 Billion Won Order
Brief: Samsung Pharmaceutical Says Acquires Shares Worth 12.5 bln Won In True Life Insurance Bank
Brief: Samsung Pharmaceutical To Invest 15.3 Billion Won To Build New Manufacturing Line
Brief: Samsung Pharmaceutical To Sell 8 Bln Won Asset To Samsung Medicos
Brief: Samsung Pharmaceutical Plans 20 Bln Won Investment In S.Korea